ask="N/A"
ask_size="N/A"
average_daily_volume="954375"
bid="N/A"
bid_size="N/A"
book_value="-0.41"
change="+0.02"
change_from_200_day_moving_average="-0.00"
change_from_50_day_moving_average="0.18"
change_from_52_week_high="-0.81"
change_From_52_week_low="0.44"
change_in_percent="+2.96%"
close="0.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.08"
ebitda="-1.60M"
eps_estimate_current_year="-0.08"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.03"
ex_dividend_date="N/A"
float_shares="133392000"
high="0.79"
high_52_weeks="1.51"
last_trade_date="3/3/2017"
last_trade_price="0.70"
last_trade_size="4500"
last_trade_time="4:02pm"
low="0.63"
low_52_weeks="0.26"
market_capitalization="108.85M"
moving_average_200_day="0.70"
moving_average_50_day="0.52"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.25"
open="0.67"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.25%"
percent_change_from_50_day_moving_average="+34.24%"
percent_change_from_52_week_high="-53.64%"
percent_change_from_52_week_low="+169.02%"
previous_close="0.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.62"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="24.06"
stock_exchange="ASE"
symbol="NAVB"
volume="4059413"
weeks_range_52="0.26 - 1.51"
